Affiliation:
1. Department of Emergency Medicine, Beyhekim Training and Research Hospital, Selcuklu, Konya, Turkey
2. Department of Emergency Medicine, Faculty of Medicine, Selcuk University, Selcuklu, Konya, Turkey
Abstract
This study, which included patients over the age of 18 who were diagnosed with coronavirus disease 2019 (COVID-19) in the emergency clinic, aims to determine the relationship between coagulation parameters and mortality. Epidemiologic data such as age, gender, medical history, vital parameters at emergency department admission, clinical findings, coagulation parameters such as d-dimer, prothrombin time (PT), active partial thromboplastin time (aPTT), international normalized ration (INR), fibrinogen, and platelet were evaluated. Patients with positive computerized tomography (CT) findings and positive polymerase chain reaction (PCR) together were included in the study. It was revealed that d-dimer, fibrinogen, INR, and PT values were higher in the elderly group. It was shown that there was a significant relationship between hospitalization days (ward or intensive care unit) and d-dimer levels. It was observed that d-dimer, fibrinogen elevation was significantly associated with prognosis by increasing mortality, and that platelet and aPTT values were also associated with prognosis and were lower in the mortality group. On the other hand, in receiver operating characteristic (ROC) analysis, the sensitivity and specificity data were 80.3%/80.0% for d-dimer, 70.5%/72.2% for fibrinogen, 58.2%/59.4% for aPTT, and 59.7%/59.2% for platelet, respectively. The overall classification success was 88.6% and mortality prediction success was 37.7% in the regression model of some coagulation parameters (d-dimer, fibrinogen, aPTT, and platelet) which were effective on prognosis. In conclusion, it was determined that d-dimer, fibrinogen, aPTT, and platelet parameters were directly associated with mortality and when these coagulation parameters were used together with the clinical, vital, and demographic data of the patients, the success of mortality prediction increased significantly.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference36 articles.
1. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019−2020.;Tan;China CDC Wkly,2020
2. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19).;Ahn;J Microbiol Biotechnol,2020
3. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19.;Böger;Am J Infect Control,2021
4. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern.;Euro Surveill,2020
5. WHO declares COVID-19 a pandemic.;Cucinotta;Acta Biomed,2020